Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0RL8P
|
||||
| Former ID |
DNC008086
|
||||
| Drug Name |
CHLOROCYCLINONE B
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529182] | ||
| Formula |
C26H21ClO9
|
||||
| Canonical SMILES |
CC1=C(C(=C2C(=C1)C=C(C3=C2C(=O)C4=CC(=C(C(=C4C3=O)O)C(C<br />)OC(=O)C)C(=O)OC)O)OC)Cl
|
||||
| InChI |
1S/C26H21ClO9/c1-9-6-12-7-15(29)19-20(17(12)25(34-4)21(9)27)22(30)13-8-14(26(33)35-5)16(10(2)36-11(3)28)23(31)18(13)24(19)32/h6-8,10,29,31H,1-5H3
|
||||
| InChIKey |
MFLXCCWOEBQIHW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | mRNA of PPAR-gamma | Target Info | Inhibitor | [529182] | |
| PANTHER Pathway | CCKR signaling map ST | ||||
| WikiPathways | Wnt Signaling Pathway Netpath | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| Differentiation of white and brown adipocyte | |||||
| Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
| Transcriptional Regulation of White Adipocyte Differentiation | |||||
| Adipogenesis | |||||
| SREBP signalling | |||||
| Nuclear Receptors | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.